title: A preliminary report on the impact of ¹⁸F-FDG PET/CT in the management of paediatric head and neck cancer.
abstract: BACKGROUND
  Paediatric head and neck malignancy accounts for 5% of all paediatric cancers. The choice of treatment and prediction of prognosis depend on the histological type of tumour, initial staging, evaluating treatment response and detection of early recurrence. Conventional imaging modalities have many limitations. Positron emission tomography/computed tomography (PET/CT) is more accurate; however, so far, the literature lacks reports of large groups of paediatric patients.
  
  
  OBJECTIVE
  To report the role of PET/CT in factors affecting the choice of treatment at the newly established Children Cancer Hospital in Cairo, Egypt, which is one of the busiest dedicated paediatric oncology centres in the world. All findings were proven by histopathology, radiology and by clinical follow-up.
  
  
  METHODS
  Thirty-six paediatric patients (30 boys and six girls) with various histologically proven head and neck cancers were included in this study. Their age ranged from 2 to 17 years. High-resolution diagnostic CT and/or MRI of the head and neck, and in relevant cases also of the chest and the abdomen, were performed in all patients at a mean interval of 1.6 weeks (range, 1-3 months) before the PET/CT study. Results of PET/CT were compared with the findings of these conventional imaging modalities.
  
  
  RESULTS
  The sensitivity, specificity, accuracy, positive and negative predictive values of PET/CT against the conventional imaging were as follows: sensitivity 100 and, 53%, specificity 89.5 and 47%, accuracy 94.5 and 50%, positive predictive value 89.5 and 47% and negative predictive value 100 and 53% respectively. PET/CT changed patient management in 50% of the cases.
  
  
  CONCLUSIONS
  PET/CT in paediatric head and neck carcinoma is more accurate than conventional imaging. Therefore, it also has a significant impact on further patient management. We recommend that it should be the first imaging modality for all purposes in initial staging, evaluating treatment response and follow-up in paediatric head and neck carcinoma.
authors.affiliation: Department of Nuclear Medicine, Children's Cancer Hospital, Cairo, Egypt. raefriad@hotmail.com
authors.forename: Raef Riad
authors.initials: RR
authors.lastname: Boktor
authors.forename: Walid S
authors.initials: WS
authors.lastname: Omar
authors.forename: Emad
authors.initials: E
authors.lastname: Mousa
authors.forename: Iman
authors.initials: I
authors.lastname: Attia
authors.forename: Amal
authors.initials: A
authors.lastname: Refaat
authors.forename: Magdy Hafez
authors.initials: MH
authors.lastname: Eltawdy
authors.forename: Alexander Gregory
authors.initials: AG
authors.lastname: Pitman
authors.forename: Hussein Mohamed
authors.initials: HM
authors.lastname: Abdel-Dayem
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D019788:Fluorodeoxyglucose F18; D006258:Head and Neck Neoplasms / Q000000981:diagnostic imaging*; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D064847:Multimodal Imaging / Q000379:methods / Q000592:standards*; D010372:Pediatrics; D049268:Positron-Emission Tomography; D011379:Prognosis; D019275:Radiopharmaceuticals; D015203:Reproducibility of Results; D012189:Retrospective Studies; D012680:Sensitivity and Specificity; D014057:Tomography, X-Ray Computed
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18